Tag: Cancer: Breast
Whole-Tumor Cell Culture Can Predict Drug Response in Breast Cancer
WTC model allows for personalized drug testing within 10 days, even for small-sized tumors
First-Line Regimens With Endocrine Therapy Show Benefits in Breast Cancer
Findings seen among subgroup of patients with human epidermal growth factor receptor 2-positive metastatic breast cancer
Commercial Rates for Breast Reconstruction Vary Significantly
Higher rates seen in less competitive markets and facilities that are large, for-profit, and non-safety net
National Cancer Institute Director Monica Bertagnolli Reveals She Has Breast Cancer
Bertagnolli plans to use her experience to 'contribute to the ever-expanding knowledge base about cancer and inform advances in care'
SABCS: Most Young Women With Breast Cancer Report Impact on Sexual Health
Vast majority also report their health care provider does not address sexual health issues
SABCS: Interrupting Endocrine Therapy Does Not Pose Breast Cancer Recurrence Risk
Findings seen among young women with early-stage, hormone receptor-positive breast cancer desiring pregnancy
Risk-Reducing Medications Can Cut Breast Cancer Death Rates
Tamoxifen with annual screening reduced invasive breast cancers and breast cancer deaths by 40 and 57 percent, respectively
SABCS: Updated Analysis Confirms Endocrine Therapy Effective With/Without Chemo
Findings seen among HR-positive, HER2-negative, node-negative early breast cancer patients with recurrence score of 11 to 25
Benefits of RT After Breast-Conserving Surgery Only Seen Within 10 Years
Findings seen at 30-year follow-up of patients who underwent breast-conserving surgery, systemic therapy for early-stage breast cancer
